Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism

This study has been completed.
Information provided by:
Federal University of São Paulo Identifier:
First received: August 15, 2006
Last updated: NA
Last verified: July 2006
History: No changes posted
The present study was designed to compare the use of mitomycin in PRK for the treatment of refractive errors and to compare these results to customized Lasik

Condition Intervention
Refractive Errors
Procedure: Prk with mitomycin vs Lasik

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism

Resource links provided by NLM:

Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • visual acuity
  • refractive errors
  • topography patterns
  • aberrometry data

Secondary Outcome Measures:
  • subjective evaluation

Estimated Enrollment: 40
Study Start Date: December 2004
Estimated Study Completion Date: October 2006

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Myopia or compound myopic astigmatism, stable refractive error, no associated eye disease

Exclusion Criteria:

  • Diabetes, autoimmune diseases, topographic abnormalities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00365040

Sponsors and Collaborators
Federal University of São Paulo
Study Chair: Mauro Campos, MD Federal University of Sao Paulo
  More Information Identifier: NCT00365040     History of Changes
Other Study ID Numbers: AWMC
Study First Received: August 15, 2006
Last Updated: August 15, 2006

Keywords provided by Federal University of São Paulo:
excimer laser

Additional relevant MeSH terms:
Refractive Errors
Eye Diseases
Antibiotics, Antineoplastic
Antineoplastic Agents
Alkylating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Enzyme Inhibitors processed this record on May 25, 2017